LINCOLN PHARMACEUTICALS
|
The Current P/S Ratio of LINCOLN PHARMACEUTICALS is 1.73.
| Share Price | ₹580.5 | Jul 27,2026 |
| Market Cap | ₹1,161.0 Cr | |
| Sales-TTM | ₹671.0 Cr | TTM-Consolidated Results |
| Price/Sales | 1.73x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LINCOLN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,161.0 Cr] as on Jul 27,2026
(/) Sales [ ₹671.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.73x ]
Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '1.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LINCOLN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of LINCOLN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of LINCOLN PHARMACEUTICALS
PS Ratio Performance Analysis for LINCOLN PHARMACEUTICALS
- LINCOLN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.50x.
- LINCOLN PHARMACEUTICALS 's operated at median p/e ratio of 1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.02x.
- LINCOLN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.06x.
How does LINCOLN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LINCOLN PHARMACEUTICALS | 671.0 | 1.73 | 1,161.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 8.10 | 473,509.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 18.64 | 196,881.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 13.65 | 190,832.0 |
| CIPLA LTD | 28,324.4 | 4.02 | 113,894.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.89 | 96,062.8 |
| MANKIND PHARMA LTD | 14,277.6 | 7.38 | 105,357.0 |
| LUPIN LTD | 27,958.0 | 3.94 | 110,189.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.07 | 110,523.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.65 | 89,114.5 |
| LAURUS LABS LTD | 7,269.6 | 12.74 | 92,612.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LINCOLN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.73x |
| Max industry PS | 18.64x |
| Median industry PS | 4.07x |
| Average industry PS | 7.26x |
You may also like the below Video Courses